Skip to main content
Erschienen in: Calcified Tissue International 6/2015

01.12.2015 | Case Reports

A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting

Erschienen in: Calcified Tissue International | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Foreign body-induced granuloma is an uncommon yet clinically significant cause of hypercalcemia. The molecular mechanisms are uncertain, although extrarenal calcitriol production has been proposed. We describe severe hypercalcemia associated with increased levels of plasma calcitriol in a patient with HIV and local granulomatous reaction 5 years after injection of polymethylmethacrylate (PMMA) as dermal filler for cosmetic body sculpting. Extensive evaluation revealed no identifiable cause of increased calcitriol levels. Nuclear imaging was remarkable for diffuse uptake in the subcutaneous tissues of the buttocks. Subsequent muscle biopsy and immunohistochemical staining showed strong local expression of CYP27B1 within histiocytes surrounding globules of PMMA. This case highlights an unfortunate complication of dermal fillers and shows that inflammatory cells can express high levels of CYP27B1 even without frank granulomas. The growing trend of body contour enhancement using injectable fillers should raise suspicion for this cause of hypercalcemia in clinical practice. Patients with HIV who receive this treatment for lipodystrophy or other cosmetic purposes may have increased susceptibility to hypercalcemia in the setting of underlying chronic inflammation. This may be a concern when changing anti-retroviral therapy, since alterations in levels of HIV viremia may initiate or contribute to worsening hypercalcemia.
Literatur
2.
Zurück zum Zitat Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10:483. doi:10.1186/1471-2407-10-483 PubMedCentralCrossRefPubMed Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F (2010) Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 10:483. doi:10.​1186/​1471-2407-10-483 PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Shultz T, Miller WC, Bedrossian CW (1979) Clinical application of measurement of angiotensin-converting enzyme level. JAMA 242(5):439–441CrossRefPubMed Shultz T, Miller WC, Bedrossian CW (1979) Clinical application of measurement of angiotensin-converting enzyme level. JAMA 242(5):439–441CrossRefPubMed
4.
5.
Zurück zum Zitat Manabe YC, Campbell JD, Sydnor E, Moore RD (2007) Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 46(4):456–462CrossRefPubMed Manabe YC, Campbell JD, Sydnor E, Moore RD (2007) Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 46(4):456–462CrossRefPubMed
7.
Zurück zum Zitat Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, Castro ND, Johnson M, Sharma A, Carr A (2013) Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART body composition substudy. J Bone Miner Res 28(6):1264–1274. doi:10.1002/jbmr.1861 PubMedCentralCrossRefPubMed Hoy J, Grund B, Roediger M, Ensrud KE, Brar I, Colebunders R, Castro ND, Johnson M, Sharma A, Carr A (2013) Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: the SMART body composition substudy. J Bone Miner Res 28(6):1264–1274. doi:10.​1002/​jbmr.​1861 PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Negri AL, Rosa Diez G, Del Valle E, Piulats E, Greloni G, Quevedo A, Varela F, Diehl M, Bevione P (2014) Hypercalcemia secondary to granulomatous disease caused by the injection of methacrylate: a case series. Clin Cases Miner Bone Metab 11(1):44–48PubMedCentralPubMed Negri AL, Rosa Diez G, Del Valle E, Piulats E, Greloni G, Quevedo A, Varela F, Diehl M, Bevione P (2014) Hypercalcemia secondary to granulomatous disease caused by the injection of methacrylate: a case series. Clin Cases Miner Bone Metab 11(1):44–48PubMedCentralPubMed
12.
13.
Zurück zum Zitat Sharma OP (2000) Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 6(5):442–447CrossRefPubMed Sharma OP (2000) Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 6(5):442–447CrossRefPubMed
14.
Zurück zum Zitat Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, Menezes J, Ferreira MC (2008) Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 121(5):1811–1820. doi:10.1097/PRS.0b013e31816b1385 PubMed Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, Menezes J, Ferreira MC (2008) Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg 121(5):1811–1820. doi:10.​1097/​PRS.​0b013e31816b1385​ PubMed
Metadaten
Titel
A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting
Publikationsdatum
01.12.2015
Erschienen in
Calcified Tissue International / Ausgabe 6/2015
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0048-8

Weitere Artikel der Ausgabe 6/2015

Calcified Tissue International 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.